NO996492L - Oppløsningsdoseringsformer av sertralin innkapslet i gelatin - Google Patents

Oppløsningsdoseringsformer av sertralin innkapslet i gelatin

Info

Publication number
NO996492L
NO996492L NO996492A NO996492A NO996492L NO 996492 L NO996492 L NO 996492L NO 996492 A NO996492 A NO 996492A NO 996492 A NO996492 A NO 996492A NO 996492 L NO996492 L NO 996492L
Authority
NO
Norway
Prior art keywords
sertraline
gelatin
encapsulated
dosage forms
solution dosage
Prior art date
Application number
NO996492A
Other languages
English (en)
Norwegian (no)
Other versions
NO996492D0 (no
Inventor
William John Curatolo
Ravi Mysore Shanker
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO996492(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO996492D0 publication Critical patent/NO996492D0/no
Publication of NO996492L publication Critical patent/NO996492L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO996492A 1997-07-01 1999-12-27 Oppløsningsdoseringsformer av sertralin innkapslet i gelatin NO996492L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01
PCT/IB1998/000936 WO1999001113A1 (fr) 1997-07-01 1998-06-16 Formes posologiques de sertraline, en solution et encapsulees dans de la gelatine

Publications (2)

Publication Number Publication Date
NO996492D0 NO996492D0 (no) 1999-12-27
NO996492L true NO996492L (no) 2000-02-29

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996492A NO996492L (no) 1997-07-01 1999-12-27 Oppløsningsdoseringsformer av sertralin innkapslet i gelatin

Country Status (40)

Country Link
EP (1) EP0980241B1 (fr)
JP (1) JP3585245B2 (fr)
KR (1) KR100371730B1 (fr)
CN (1) CN1261792A (fr)
AP (1) AP945A (fr)
AR (1) AR015916A1 (fr)
AT (1) ATE256457T1 (fr)
AU (1) AU724635B2 (fr)
BG (1) BG103917A (fr)
BR (1) BR9809712A (fr)
CA (1) CA2290973C (fr)
CO (1) CO4940405A1 (fr)
DE (1) DE69820608T2 (fr)
DK (1) DK0980241T3 (fr)
DZ (1) DZ2544A1 (fr)
EA (1) EA001905B1 (fr)
ES (1) ES2210760T3 (fr)
GT (1) GT199800090A (fr)
HR (1) HRP980378B1 (fr)
HU (1) HUP0002250A3 (fr)
ID (1) ID24673A (fr)
IL (1) IL133075A0 (fr)
IS (1) IS5266A (fr)
MA (1) MA24586A1 (fr)
MY (1) MY119728A (fr)
NO (1) NO996492L (fr)
NZ (1) NZ501252A (fr)
OA (1) OA11246A (fr)
PA (1) PA8454001A1 (fr)
PE (1) PE97299A1 (fr)
PL (1) PL337807A1 (fr)
PT (1) PT980241E (fr)
SK (1) SK282914B6 (fr)
TN (1) TNSN98123A1 (fr)
TR (1) TR199903282T2 (fr)
TW (1) TW382597B (fr)
UA (1) UA68350C2 (fr)
UY (1) UY25070A1 (fr)
WO (1) WO1999001113A1 (fr)
ZA (1) ZA985709B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2001002119A0 (en) * 1998-10-13 2001-03-22 Pfizer Prod Inc Sertraline oral concentrate.
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
ES2256032T3 (es) 1999-09-03 2006-07-16 Apbi Holdings, Llc Utilizacion de dapoxetina, un inhibidor selectivo de la recaptacion de serotonina, para el tratamiento de una disfuncion sexual.
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
EP1375659A1 (fr) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Mélanges concentrés dans des capsules solubles pour la préparation facilitée de solutions chimiques ou biologiques
CN1728982A (zh) * 2002-10-31 2006-02-01 阿尔扎公司 可增加疏水性药物生物利用度的药物制剂
WO2016020936A2 (fr) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal Nouvelle forme posologique pharmaceutique orale de rétention gastrique
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0782445T3 (da) * 1994-09-19 2002-05-06 Bristol Myers Squibb Pharma Co Kombination af en opioidantagonist og en selektiv serotoningenoptagelsesinhibitor til behandling af alkoholisme og alkoholafhængighed
EP0768083B1 (fr) * 1995-07-17 2003-03-26 Pfizer Inc. Sertraline pour le traitement des patients post-infarction myocardique

Also Published As

Publication number Publication date
AP945A (en) 2001-02-28
ID24673A (id) 2000-07-27
DE69820608T2 (de) 2004-12-23
PT980241E (pt) 2004-03-31
UA68350C2 (en) 2004-08-16
JP2000512316A (ja) 2000-09-19
CN1261792A (zh) 2000-08-02
PE97299A1 (es) 1999-10-13
GT199800090A (es) 1999-12-21
MY119728A (en) 2005-07-29
NZ501252A (en) 2004-11-26
HUP0002250A2 (hu) 2000-12-28
PL337807A1 (en) 2000-09-11
OA11246A (en) 2002-11-19
DE69820608D1 (de) 2004-01-29
AR015916A1 (es) 2001-05-30
TR199903282T2 (xx) 2000-08-21
TNSN98123A1 (fr) 2005-03-15
MA24586A1 (fr) 1998-12-31
ZA985709B (en) 2000-01-10
HUP0002250A3 (en) 2001-01-29
EP0980241A1 (fr) 2000-02-23
KR20010013588A (fr) 2001-02-26
CO4940405A1 (es) 2000-07-24
CA2290973C (fr) 2003-06-17
HRP980378B1 (en) 2001-12-31
JP3585245B2 (ja) 2004-11-04
EA199900963A1 (ru) 2000-08-28
SK282914B6 (sk) 2003-01-09
PA8454001A1 (es) 2000-05-24
CA2290973A1 (fr) 1999-01-14
DK0980241T3 (da) 2004-04-05
TW382597B (en) 2000-02-21
BR9809712A (pt) 2000-07-11
WO1999001113A1 (fr) 1999-01-14
EP0980241B1 (fr) 2003-12-17
UY25070A1 (es) 2000-12-29
DZ2544A1 (fr) 2003-02-08
AP9801279A0 (en) 1998-06-30
KR100371730B1 (ko) 2003-02-07
HRP980378A2 (en) 1999-04-30
NO996492D0 (no) 1999-12-27
ATE256457T1 (de) 2004-01-15
IL133075A0 (en) 2001-03-19
IS5266A (is) 1999-11-23
AU724635B2 (en) 2000-09-28
SK180599A3 (en) 2001-01-18
AU7545098A (en) 1999-01-25
BG103917A (bg) 2000-07-31
ES2210760T3 (es) 2004-07-01
EA001905B1 (ru) 2001-10-22

Similar Documents

Publication Publication Date Title
DE69829139D1 (de) Medikator vom ansangtyp
ATE298241T1 (de) Behandlung von atemstillstand im schlaf
ATE438305T1 (de) Verkapselung von komponenten in essbaren produkten
NO944046D0 (no) Ökning av medikamentrespons
DE19681727T1 (de) Kapseln/Teilchen enthaltende Shampoo-Zusammensetzung
DE69535102D1 (de) Einkapselung von optoelektronischen bauteilen
ID17794A (id) Bentuk dosis gelatin lunak multi fasa
DE69823360D1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
FI956073A (fi) Pehmeäkuoriset gelatiiniin kapseloidut osaset
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
DE69801392D1 (de) Herstellung von Methylchlorid
NO996492D0 (no) Opploesningsdoseringsformer av sertralin innkapslet i gelatin
ATE245415T1 (de) Verabreichungsform für sertralin mit verzögerter wirkstofffreigabe
EA199900672A1 (ru) Гомеопатическое лекарственное средство
DE59807819D1 (de) Duftstoff-enthaltende Zubereitung
EA199900673A1 (ru) Гомеопатическое лекарственное средство
DE69811864D1 (de) Herstellung von bandförmigen werkstücken
DE59812225D1 (de) Einkapseln von wasserunlöslichen wirkstoffen mit amphiphilem charakter
DE69613921D1 (de) Herstellung von Methylaminen
SE8900772D0 (sv) Anvaending av gelatinhydrolysat i konfektyr
KR950026338U (ko) 한약재를 이용한 미용발향제의 허리띠
UA1951S (uk) Етикетка медичного препарату "валідол"
UA2094S (uk) Етикетка медичного препарату "аспаркам"
UA1957S (uk) Етикетка медичного препарату "аспаркам"
UA1758S (uk) Комплект етикеток

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application